Table 2.
HPV positive participants |
Multiple HPV positive participants |
|||
---|---|---|---|---|
n | % (95% CI) | n | % (95% CI) | |
HPV |
121 |
28.0 (23.9-32.5) |
54 |
100 |
One HPV type |
67 |
15.5 (12.3-19.4) |
- |
- |
Multiple HPV types |
54 |
12.5 (9.6-16.1) |
- |
- |
HR-HPV |
107 |
24.8 (20.8-29.2) |
53 |
98.1 (90.1-100.0) |
LR-HPV |
32 |
7.4 (5.2-10.4 |
19 |
5.8 (3.6-9.0) |
HPV 16 |
29 |
6.7 (4.6-9.6) |
21 |
38.9 (25.9-53.1) |
HPV 51 |
22 |
5.1 (3.3-7.7) |
18 |
33.3 (21.1-47.5) |
HPV 31 |
20 |
4.6 (2.9-7.2) |
12 |
22.0 (12.0-35.6) |
HPV 52 |
18 |
4.2 (2.6-6.6) |
10 |
18.5 (9.3-31.4) |
HPV 18 |
15 |
3.5 (2.0-5.8) |
12 |
22.2 (12.0-35.6) |
HPV 53 |
11 |
2.5 (1.3-4.6) |
11 |
20.4 (10.6-36.5) |
HPV 58 |
10 |
2.3 (1.2-4.4) |
8 |
14.8 (6.6-27.1) |
HPV 39 |
9 |
2.1 (1.0-4,1) |
8 |
14.8 (6.6-27.1) |
HPV 6 |
7 |
1.6 (0.7-3.5) |
6 |
11.1 (4.2-22.6) |
HPV 45 |
6 |
1.4 (0.6-3.2) |
1 |
1.9 (0.0-9.9) |
HPV 66 |
6 |
1.4 (0.6-3.2) |
3 |
5.6 (1.2-15.4) |
HPV 73 |
6 |
1.4 (0.6-3.2) |
2 |
3.7 (0.5-12.7) |
HPV 42 |
5 |
1.2 (0.4-2.8) |
3 |
5.6 (1.2-15.4) |
HPV 54 |
5 |
1.2 (0.4-2.8) |
2 |
3.7 (0.5-12.7) |
HPV 26 |
4 |
0.9 (0.3-2.5) |
2 |
3.7 (0.5-12.7) |
HPV 33 |
4 |
0.9 (0.3-2.5) |
3 |
5.6 (1.2-15.4) |
HPV 56 |
4 |
0.9 (0.3-2.5) |
2 |
3.7 (0.5-12.7) |
HPV 68 |
4 |
0.9 (0.3-2.5) |
3 |
5.6 (1.2-15.4) |
HPV 40 |
3 |
0.7 (0.2-2.2) |
1 |
1.9 (0.0-9.9) |
HPV 84 |
3 |
0.7 (0.2-2.2) |
3 |
5.6 (1.2-15.4) |
HPV 35 |
2 |
0.5 (0.1-1.8) |
2 |
3.7 (0.5-12.7) |
HPV 70 |
2 |
0.5 (0.1-1.8) |
0 |
- |
HPV 55 |
2 |
0.5 (0.1-1.8) |
1 |
1.9 (0.0-9.9) |
HPV 61 |
2 |
0.5 (0.1-1.8) |
0 |
- |
HPV 62 |
2 |
0.5 (0.1-1.8) |
2 |
3.7 (0.5-12.7) |
HPV 59 |
1 |
0.2 (0.0-1.5) |
1 |
1.9 (0.0-9.9) |
HPV 82 |
1 |
0.2 (0.0-1.5) |
1 |
1.9 (0.0-9.9) |
HPV 11 |
1 |
0.2 (0.0-1.5) |
0 |
- |
HPV 89 |
1 |
0.2 (0.0-1.5) |
1 |
1.9 (0.0-9.9) |
HPV 44 | 1 | 0.2 (0.0-1.5) | 0 | - |
HPV: human papillomavirus; CI: confidence interval; n: number of participants; HR-HPV: high-risk HPV; LR-HPV: low-risk HPV.